Akari Therapeutics Announces Successful $2 Million Private Placement Financing
Akari Therapeutics, a biopharmaceutical company listed on NASDAQ under the ticker symbol AKTX, has recently announced the successful closure of a private placement financing round. The financing involved existing investors, namely Akari Chairman Ray Prudo and Director Samir Patel, and has resulted in gross proceeds of approximately $2 million. As part of the private placement…